April 14, 2021
Notice of Annual General Meeting of LIDDS AB (publ)
UPPSALA, SWEDEN – The shareholders of LIDDS AB (publ), corp. ID no. 556580-2856, are invited to the Annual General Meeting…
Pharmaceuticals, Biotechnology and Life Sciences
Author: GlobeNewswire
April 14, 2021
Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
On track to initiate Phase 1 trials for four wholly owned drug candidates in 2021 Expanded Sanofi collaboration resulting in…
April 14, 2021
Tauriga Sciences Inc. to Launch Non-Fungible Tokens (NFTs) Creation & Content Division, as Part of its Long-Term Branding, Marketing, and Monetization Strategies
04_13_2021 PR Image An Example of NFT Tauri-Gum™ Art Content The Company’s Newly Formed Division Will be Called: NFTauriga Corp.…
April 14, 2021
Nicox: 2021 Ordinary and Extraordinary General Meetings postponed to April 28, 2021
Press ReleaseNicox: 2021 Ordinary and Extraordinary General Meetings postponed to April 28, 2021 April 13, 2021 Sophia Antipolis, France Nicox…
April 13, 2021
Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
Company announcement – No. 21/ 2021 Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and…
April 13, 2021
Lixte Biotechnology Holdings, Inc. Announces the Appointment of Gil N Schwartzberg to its Board of Directors
EAST SETAUKET, New York, April 13, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (“Lixte” or the “Company”) (Nasdaq: LIXT),…
April 13, 2021
NKMax and Merck KGaA, Darmstadt, Germany Expand Clinical Collaboration to Include Phase I/IIa Trial Investigating the Combination of SNK01 with ERBITUX® (cetuximab) in Metastatic NSCLC
SEOUL, South Korea, April 13, 2021 (GLOBE NEWSWIRE) — NKMax, a biotechnology company harnessing the power of the body’s immune…
April 13, 2021
Passing of Genmab A/S’ Annual General Meeting
Company Announcement At Genmab A/S’ Annual General Meeting held today April 13, 2021, the Annual Report for 2020 was approvedDischarge…
April 13, 2021
A civil case has been initiated in the claim of JSC Olainfarm for the damage caused
Pursuant to the decision of the shareholders’ meeting of September 22, 2020, the Management Board of JSC Olainfarm has filed…
April 13, 2021
SEngine Precision Medicine Presents Data at 2021 AACR Annual Meeting Demonstrating Clinical Utility and Predictive Value of PARIS® Test in Ovarian Cancer
SEATTLE, April 13, 2021 (GLOBE NEWSWIRE) — SEngine Precision Medicine, a precision oncology company that pre-tests drugs on patient-derived live tumor…